Format

Send to

Choose Destination
Leukemia. 2019 Apr;33(4):1030-1051. doi: 10.1038/s41375-018-0335-2. Epub 2019 Jan 3.

Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment.

Author information

1
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
2
Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and UniversitĂ  Vita-Salute San Raffaele, Milan, Italy.
3
Divisione di Ematologia dell'UniversitĂ  di Torino, Azienda Ospedaliero Universitaria S. Giovanni Battista di Torino, Torino, Italy.
4
Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy.
5
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
6
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. kostas.stamatopoulos@gmail.com.
7
Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. kostas.stamatopoulos@gmail.com.
PMID:
30607020
DOI:
10.1038/s41375-018-0335-2

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center